Jank, B.J.; Haas, M.; Schnoell, J.; Schlederer, M.; Heiduschka, G.; Kenner, L.; Kadletz-Wanke, L.
µ-Crystallin Is Associated with Disease Outcome in Head and Neck Squamous Cell Carcinoma. J. Pers. Med. 2021, 11, 1330.
https://doi.org/10.3390/jpm11121330
AMA Style
Jank BJ, Haas M, Schnoell J, Schlederer M, Heiduschka G, Kenner L, Kadletz-Wanke L.
µ-Crystallin Is Associated with Disease Outcome in Head and Neck Squamous Cell Carcinoma. Journal of Personalized Medicine. 2021; 11(12):1330.
https://doi.org/10.3390/jpm11121330
Chicago/Turabian Style
Jank, Bernhard J., Markus Haas, Julia Schnoell, Michaela Schlederer, Gregor Heiduschka, Lukas Kenner, and Lorenz Kadletz-Wanke.
2021. "µ-Crystallin Is Associated with Disease Outcome in Head and Neck Squamous Cell Carcinoma" Journal of Personalized Medicine 11, no. 12: 1330.
https://doi.org/10.3390/jpm11121330
APA Style
Jank, B. J., Haas, M., Schnoell, J., Schlederer, M., Heiduschka, G., Kenner, L., & Kadletz-Wanke, L.
(2021). µ-Crystallin Is Associated with Disease Outcome in Head and Neck Squamous Cell Carcinoma. Journal of Personalized Medicine, 11(12), 1330.
https://doi.org/10.3390/jpm11121330